Price$4.69-0.32 (-6.39%)
2026-03-052026-06-08
News · 26 weeks27+25%
2025-12-142026-06-07
Mix1390d
- SEC Filings8(62%)
- Other3(23%)
- Earnings2(15%)
Latest news
25 items- SECSEC Form 8-K filed by DNA X Inc.8-K - DNA X, Inc. (0001178697) (Filer)
- SECDNA X Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - DNA X, Inc. (0001178697) (Filer)
- PRDNA X, Inc. Reports First Quarter 2026 Financial ResultsClosed sale of the Company's mobile device assets to NEXA in January 2026Completed the transfer of the operations of the phone and hotspot business to NEXAFocused on enhancing the DNA X trading platform to prepare the platform for its initial growth phaseSan Diego, California--(Newsfile Corp. - May 20, 2026) - DNA X, Inc. (NASDAQ:SONM), a provider of cryptocurrency trading services, today announced its financial results for the first quarter ended March 31, 2026. The company operates the DNA X AI trading platform business, and expects to launch an enhanced version to the public later this year. The platform is designed to harness advanced AI and machine learning technologies to automate inte
- SECSEC Form 10-Q filed by DNA X Inc.10-Q - DNA X, Inc. (0001178697) (Filer)
- SECDNA X Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - DNA X, Inc. (0001178697) (Filer)
- SECSEC Form NT 10-Q filed by DNA X Inc.NT 10-Q - DNA X, Inc. (0001178697) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by DNA X Inc.SCHEDULE 13G/A - DNA X, Inc. (0001178697) (Subject)
- SECAmendment: SEC Form 10-K/A filed by DNA X Inc.10-K/A - DNA X, Inc. (0001178697) (Filer)
- SECDNA X Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits8-K - DNA X, Inc. (0001178697) (Filer)
- SECSEC Form 10-K filed by DNA X Inc.10-K - DNA X, Inc. (0001178697) (Filer)
- SECDNA X Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - DNA X, Inc. (0001178697) (Filer)
- PRDNA X, Inc. Reports Full Year 2025 Financial ResultsCompleted acquisition of the DNA X cryptocurrency trading platformClosed sale of the Company's mobile device assets to NEXA in January 2026Focused on enhancing the DNA X trading platform to prepare the platform for its initial growth phaseSan Diego, California--(Newsfile Corp. - April 14, 2026) - DNA X, Inc. (NASDAQ:SONM), a provider of cryptocurrency trading services, today announced its financial results for the fourth quarter and full year ended December 31, 2025. The company purchased the DNA X cryptocurrency trading platform business in December 2025, following the launch of the DNA X.us website in November 2025 that is now active. The platform is designed to take advantage of movements
- SECSEC Form NT 10-K filed by DNA X Inc.NT 10-K - DNA X, Inc. (0001178697) (Filer)
- SECAmendment: DNA X Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits8-K/A - DNA X, Inc. (0001178697) (Filer)
- INSIDERNew insider Dna Holdings Venture Inc. claimed ownership of 223,201 shares (SEC Form 3)3 - DNA X, Inc. (0001178697) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Sonim Technologies Inc.SCHEDULE 13G/A - DNA X, Inc. (0001178697) (Subject)
- INSIDERChief Financial Officer Crolius Clayton was granted 35,000 shares, increasing direct ownership by 2,036% to 36,719 units (SEC Form 4)4 - DNA X, Inc. (0001178697) (Issuer)
- INSIDERActing CEO Mulica Michael C was granted 50,000 shares, increasing direct ownership by 1,228% to 54,071 units (SEC Form 4)4 - DNA X, Inc. (0001178697) (Issuer)
- SECSEC Form 8-K filed by Sonim Technologies Inc.8-K - DNA X, Inc. (0001178697) (Filer)
- SECSonim Technologies Inc. filed SEC Form 8-K: Leadership Update8-K - DNA X, Inc. (0001178697) (Filer)
- SECSonim Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - DNA X, Inc. (0001178697) (Filer)
- PRSonim Technologies Public Entity Rebrands As DNA X, Inc., A Digital Asset Management CompanySan Diego, California--(Newsfile Corp. - January 27, 2026) - Sonim Technologies (NASDAQ:SONM) announced today that it is being renamed DNA X, Inc. concurrent with the previously announced asset sale to NEXA® (formerly Social Mobile).The proceeds generated from this transaction are anticipated to fund debt retirement and provide working capital for the company's digital asset management operations.Going forward, DNA X, Inc. will operate DNA X, the digital asset trading platform that Sonim acquired in December 2025. In conjunction with the asset divestiture, the corporate name of Sonim Technologies has been officially changed to DNA X, Inc. While the company will temporarily retain the Nasdaq
- PRSonim Technologies Stockholders Approve Asset Sale to NEXA, Clearing Path for Strategic TransitionStockholder approval enables closing of the Sonim asset sale in January 2026NEXA to continue selling rugged phones and mobile hotspots under the Sonim brandTransaction allows Sonim to retire debt and provides working capital for new, independent businessPublic company to rebrand and focus exclusively on DNA X, a crypto trading platformSan Diego, California--(Newsfile Corp. - December 31, 2025) - Sonim Technologies, Inc. (NASDAQ:SONM) today announced that its stockholders approved the previously announced Asset Purchase Agreement with NEXA® (formerly Social Mobile) at a special meeting held on December 30, 2025.The approval authorizes Sonim to complete the sale of substantially all assets rel
- SECSonim Technologies Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - SONIM TECHNOLOGIES INC (0001178697) (Filer)
- SECSEC Form DEFA14A filed by Sonim Technologies Inc.DEFA14A - SONIM TECHNOLOGIES INC (0001178697) (Filer)
SONM FAQ
6 questionsWhat does DNA X Inc. do?
Sonim Technologies, Inc. provides ruggedized mobile phones and accessories for task workers. It offers ruggedized mobile phones, such as Sonim XP8, Sonim XP5s, and Sonim XP3 based on the Android platform that are capable of attaching to public and private wireless networks; industrial-grade accessories, including remote speaker microphones, multi-bay charging accessories, and in-vehicle hands-free voice communications solutions; cloud-based software and application services; and Rapid Deployment Kit, a portable communications system. The company also provides SmartScanner products, such as...Where does SONM stock trade?
DNA X Inc. (SONM) is listed on NASDAQ.What sector and industry is SONM in?
DNA X Inc. operates in the Utilities sector, Telecommunications Equipment industry.When did DNA X Inc. go public?
DNA X Inc. (SONM) completed its IPO in 2019.What companies are similar to SONM?
Notable peers in the same industry include TMUS (T-Mobile US Inc.), VZ (Verizon Communications Inc.), T (AT&T Inc.), GLW (Corning Incorporated), AMX (America Movil S.A.B. de C.V.). Compare SONM side-by-side with any of them on Quantisnow.How can I track SONM on Quantisnow?
Quantisnow aggregates DNA X Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SONM to receive live email and push alerts on every new disclosure.